Relevant bibliographies by topics / Peptide intestinal

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Peptide intestinal'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Peptide intestinal.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Peptide intestinal"

1

Ganapathy, Vadivel, and Frederick H. Leibach. "Is intestinal peptide transport energized by a proton gradient?" American Journal of Physiology-Gastrointestinal and Liver Physiology 249, no. 2 (1985): G153—G160. http://dx.doi.org/10.1152/ajpgi.1985.249.2.g153.

Full text
Abstract:
Transport of intact peptides, followed by intracellular hydrolysis in the intestinal mucosal cells, plays an important role in the absorption of protein digestion products in the mammalian small intestine. Even though earlier studies on peptide absorption in intact-tissue preparations have indicated that peptides are transported by an active Na+-dependent mechanism, recent studies with purified brush-border membrane vesicles have unequivocally demonstrated that Na+ does not play a direct role in the translocation of peptides across the membrane. Like most amino acids, peptides are also transpo
APA, Harvard, Vancouver, ISO, and other styles
2

Shimizu, Yuriko, Satohiro Masuda, Kumiko Nishihara, Lin Ji, Masahiro Okuda, and Ken-ichi Inui. "Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats." American Journal of Physiology-Gastrointestinal and Liver Physiology 288, no. 4 (2005): G664—G670. http://dx.doi.org/10.1152/ajpgi.00270.2004.

Full text
Abstract:
In chronic renal failure (CRF), dietary protein is one of the factors that deteriorates residual renal functions. Numerous studies have indicated that the products of protein digestion are mainly absorbed as small peptides. However, how small peptides are absorbed in CRF remains poorly understood. H+-coupled peptide transporter (PEPT1/ SLC15A1) plays an important role in the absorption of small peptides and peptide-like drugs in the small intestine. Because dietary protein intake is one of the risk factors for renal failure, the alteration of intestinal PEPT1 might have implications in the pro
APA, Harvard, Vancouver, ISO, and other styles
3

Gill, J. S., Y. Yiangou, D. J. Webb, et al. "Peptide histidine valine: Its haemodynamic actions and pharmacokinetics in man differ from those of vasoactive intestinal peptide and peptide histidine methionine." Clinical Science 78, no. 5 (1990): 487–92. http://dx.doi.org/10.1042/cs0780487.

Full text
Abstract:
1. The effects of intravenous and intra-arterial infusion of the peptides derived from prepro-vasoactive intestinal peptide, vasoactive intestinal peptide, peptide histidine methionine and peptide histidine valine, were examined in six healthy volunteers. 2. Vasoactive intestinal peptide given intravenously caused a significant increase in heart rate and a decrease in diastolic, but not systolic, blood presure, whereas peptide histidine valine caused an increase in heart rate alone, despite higher achieved circulating peptide concentrations. Peptide histidine methionine did not affect heart ra
APA, Harvard, Vancouver, ISO, and other styles
4

Pan, Xiaoyue, Tomohiro Terada, Megumi Irie, Hideyuki Saito, and Ken-Ichi Inui. "Diurnal rhythm of H+-peptide cotransporter in rat small intestine." American Journal of Physiology-Gastrointestinal and Liver Physiology 283, no. 1 (2002): G57—G64. http://dx.doi.org/10.1152/ajpgi.00545.2001.

Full text
Abstract:
In mammals, most physiological, biochemical, and behavioral processes show a circadian rhythm. In the present study, we examined the diurnal rhythm of the H+-peptide cotransporter (PEPT1), which transports small peptides and peptide-like drugs in the small intestine and kidney, using rats maintained in a 12-h photoperiod with free access to chow. The transport of [14C]glycylsarcosine (Gly-Sar), a typical substrate for PEPT1 by in situ intestinal loop and everted intestine, was greater in the dark phase than the light phase. PEPT1 protein and mRNA levels varied significantly, with a maximum at
APA, Harvard, Vancouver, ISO, and other styles
5

Lord, A. P. D., A. A. Martin, F. J. Ballard, and L. C. Read. "Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins." Journal of Endocrinology 141, no. 3 (1994): 505–15. http://dx.doi.org/10.1677/joe.0.1410505.

Full text
Abstract:
Abstract The net transfer of 125I-labelled insulin-like growth factor (IGF)-I from the blood to the distal small intestine was measured in anaesthetized lambs using a non-recirculating vascular-perfused intestine. To determine whether IGF-binding proteins (IGFBPs) reduce net IGF transfer, radio-labelled IGF-I was compared with two analogues, des(1–3)IGF-I and LR3IGF-I, which show reduced affinity for IGFBPs. Radiolabelled IGF-I, des(1–3)IGF-I or LR3IGF-I (1 ng/ml plasma) was infused for 45 min into the arterial supply of a 10 cm intestinal segment, either in the absence of added unlabelled pep
APA, Harvard, Vancouver, ISO, and other styles
6

Hausch, Felix, Lu Shan, Nilda A. Santiago, Gary M. Gray, and Chaitan Khosla. "Intestinal digestive resistance of immunodominant gliadin peptides." American Journal of Physiology-Gastrointestinal and Liver Physiology 283, no. 4 (2002): G996—G1003. http://dx.doi.org/10.1152/ajpgi.00136.2002.

Full text
Abstract:
Two recently identified immunodominant epitopes from α-gliadin account for most of the stimulatory activity of dietary gluten on intestinal and peripheral T lymphocytes in patients with celiac sprue. The proteolytic kinetics of peptides containing these epitopes were analyzed in vitro using soluble proteases from bovine and porcine pancreas and brush-border membrane vesicles from adult rat intestine. We showed that these proline-glutamine-rich epitopes are exceptionally resistant to enzymatic processing. Moreover, as estimated from the residual peptide structure and confirmed by exogeneous pep
APA, Harvard, Vancouver, ISO, and other styles
7

Ménard, Sandrine, Valentina Förster, Michael Lotz, et al. "Developmental switch of intestinal antimicrobial peptide expression." Journal of Experimental Medicine 205, no. 1 (2008): 183–93. http://dx.doi.org/10.1084/jem.20071022.

Full text
Abstract:
Paneth cell–derived enteric antimicrobial peptides provide protection from intestinal infection and maintenance of enteric homeostasis. Paneth cells, however, evolve only after the neonatal period, and the antimicrobial mechanisms that protect the newborn intestine are ill defined. Using quantitative reverse transcription–polymerase chain reaction, immunohistology, reverse-phase high-performance liquid chromatography, and mass spectrometry, we analyzed the antimicrobial repertoire in intestinal epithelial cells during postnatal development. Surprisingly, constitutive expression of the cathelin
APA, Harvard, Vancouver, ISO, and other styles
8

Selsted, M. E., S. I. Miller, A. H. Henschen, and A. J. Ouellette. "Enteric defensins: antibiotic peptide components of intestinal host defense." Journal of Cell Biology 118, no. 4 (1992): 929–36. http://dx.doi.org/10.1083/jcb.118.4.929.

Full text
Abstract:
Five intestinal defensins, termed cryptdins 1-5, have been purified from mouse small bowel, sequenced, and localized to the epithelium by immunohistochemistry. Although identified as members of the defensin peptide family by peptide sequencing, enteric defensins are novel in that four cryptdins have amino termini which are three to six residues longer than those of leukocyte-derived defensins. A fifth cryptdin is the first defensin to diverge from the previously invariant spacing of cysteines in the peptide structure. The most abundant enteric defensin, cryptdin-1, had antimicrobial activity a
APA, Harvard, Vancouver, ISO, and other styles
9

Said, Sami I. "Vasoactive intestinal peptide." Journal of Endocrinological Investigation 9, no. 2 (1986): 191–200. http://dx.doi.org/10.1007/bf03348097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Grider, J. R., M. B. Cable, K. N. Bitar, S. I. Said, and G. M. Makhlouf. "Vasoactive intestinal peptide." Gastroenterology 89, no. 1 (1985): 36–42. http://dx.doi.org/10.1016/0016-5085(85)90742-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Peptide intestinal"

1

Zaben, Malik J. "Vasoactive Intestinal Peptide : Control of Hippocampal Neurogenesis." Thesis, University of Southampton, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509485.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Henderson, Fiona D. "Characterisation of the intestinal basolateral peptide transporter." Thesis, University of Newcastle Upon Tyne, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.289253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Picker, Jonathan David. "Regulation of the human intestinal peptide transporter hPepT1." Thesis, University of Newcastle Upon Tyne, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262897.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Menez, Isabelle. "Mise en évidence des sites de liaison du peptide vasoactif intestinal (V. I. P. ) dans les membranes antrales humaines." Paris 7, 1985. http://www.theses.fr/1985PA07F082.

Full text
Abstract:
Nous mettons en évidence pour la première fois l'existence de sites de liaisons spécifiques pour le VIP radioiodé dans le tissu gastrique. Cette étude, entreprise au niveau de préparations membranaires de l'antre et du fundus humain, est couplée à la caractérisation de l'adénylate cyclase sensible au VIP dans les mêmes conditions expérimentales chez l'homme et au niveau de l'antre de cobaye. Les différents paramètres étudiés pour la liaison du VIP -I¹²⁵ sont les suivants: association, dissociation, dégradation, température, concentration membranaire, pH, guanyl nucléotides, spécificité tissula
APA, Harvard, Vancouver, ISO, and other styles
5

Meissner, Barbara. "Phenotype analysis of Caenorhabditis elegans lacking the intestinal peptide transporter." [S.l. : s.n.], 2004. http://deposit.ddb.de/cgi-bin/dokserv?idn=972045376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fischer, Kirk D. "Intestinal growth in models of glucagon-like peptide-2 overexpression." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape16/PQDD_0008/MQ29340.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Luis, José. "Structure et dynamique du récepteur du peptide vasoactif intestinal (VIP)." Grenoble 2 : ANRT, 1987. http://catalogue.bnf.fr/ark:/12148/cb376074919.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Luis, José. "Structure et dynamique du récepteur du peptide vasoactif intestinal (VIP)." Aix-Marseille 1, 1987. http://www.theses.fr/1987AIX11068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wallis, Katharina. "Studies into the intestinal growth factor glucagon-like peptide-2." Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/5581.

Full text
Abstract:
Glucagon-like peptide-2 (GLP-2) is a peptide hormone, secreted postprandially from enteroendocrine L-cells. GLP-2 has emerged as a central physiological mediator of intestinal growth and integrity and has recently shown promise as a therapeutic agent in patients with short bowel syndrome and inflammatory bowel disease. Reliable methods for GLP-2 measurement are not widely available. In this work a radioimmunoassay (RIA), using the GLP-2 antiserum (FT-17) has been optimised and validated. Cross-reactivity with GLP-2 precursors and degradation products was investigated using column chromatograph
APA, Harvard, Vancouver, ISO, and other styles
10

Liu, Kuan-Ling. "Delayed access to feed affects broiler small intestinal morphology and intestinal cell ontogeny." Thesis, Virginia Tech, 2019. http://hdl.handle.net/10919/102025.

Full text
Abstract:
In the broiler industry, chicks are often deprived of feed and water up to 48 h posthatch. This delayed access to feed (DAF) has been found to inhibit small intestinal development, compromising growth of the chick. To further understand the impact of DAF on small intestines at the molecular level, many developmental genes that regulate intestinal development were investigated. The objective of this study was to determine the effect of DAF on early posthatch broiler small intestinal morphology, which includes villus height (VH) and crypt depth (CD), and to quantify changes in regulatory genes,
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Peptide intestinal"

1

G, Rosselin, ed. International Symposium on Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Polypeptide & Related Regulatory Peptides: From molecular biology to clinical applications : Euroconference, Strasbourg (Bischenberg), 19-23, September 1993. World Scientific, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fischer, Kirk D. Intestinal growth in models of glucagon-like peptide-2 overexpression. National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

International Symposium on VIP and Related Peptides (5th 1991 Shizuoka, Japan). Vasoactive intestinal peptide and related peptides: Proceedings of the Fifth International Symposium on VIP and Related Peptides, Shizuoka, Japan, November 12-15, 1991. Edited by Yanaihara Noboru. Biomedical Research Foundation, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1930-, Bevan John A., ed. Vascular neuroeffector mechanisms: Receptors, ion-channels, second messengers, and endogenous mediators : proceedings of the Sixth International Symposium on Vascular Neuroeffector Mechanisms, Melbourne, Australia, August 30-September 2, 1987. Published for the ICSU Press by IRL Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nicklin, Paul Leslie. Amino acid, peptide and drug transport across monolayers of human intestinal (CAC0-2) cells in vitro. Aston University. Department of Pharmaceutical Sciences., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

International Symposium on "Vasoactive Intestinal Peptide (VIP) and Related Peptides" (2nd 1985 Cap d'Agde, France). Abstracts of the second International Symposium on "Vasoactive Intestinal Peptide (VIP) and Related Peptides": Cap d'Agde, Hérault, France, june 18-22, 1985. Elsevier Science Publishers, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hubert, Vaudry, and Laburthe Marc, eds. VIP, PACAP, and related peptides: From gene to therapy. Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Indigestion: Living better with upper intestinal problems from heartburn to ulcers and gallstones. Consumer Reports Books, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Indigestion: Living better with upper intestinal problems from heartburn to ulcers and gallstones. Oxford University Press, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Davis, Micheal D. The isolation of novel insulin-releasing peptides from the small intestine of the obese hyperglycaemic (ob/ob)mouse. The Author], 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Peptide intestinal"

1

Said, Sami I. "Vasoactive Intestinal Peptide." In Airways Smooth Muscle: Peptide Receptors, Ion Channels and Signal Transduction. Birkhäuser Basel, 1995. http://dx.doi.org/10.1007/978-3-0348-7362-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Seth, John. "Vasoactive Intestinal Peptide." In The Immunoassay Kit Directory. Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1414-1_57.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dimaline, Rod. "Vasoactive intestinal peptide." In The Comparative Physiology of Regulatory Peptides. Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-0835-2_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gozes, Illana, and Mati Fridkin. "Lipophilic vasoactive intestinal peptide: Potential drug for non-invasive impotence treatment." In Peptide Chemistry 1992. Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1474-5_131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Paul, S., and R. J. Massey. "Autoabzyme Catalyzed Cleavage of Vasoactive Intestinal Peptide." In Progress in Immunology. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83755-5_113.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ouellette, Andre J., and Michael E. Selsted. "Antimicrobial Peptide Effectors of Small Intestinal Innate Immunity." In Microbial Pathogenesis and the Intestinal Epithelial Cell. ASM Press, 2014. http://dx.doi.org/10.1128/9781555817848.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bolin, David R., Jeanine M. Cottrell, Ryuko Senda, et al. "Identification of the binding pharmacophores of vasoactive intestinal peptide (VIP)." In Peptides. Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2264-1_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gozes, Illana, and Douglas E. Brenneman. "Vasoactive Intestinal Peptide: From Molecular Genetics to Neurotropism." In Growth Factors, Peptides and Receptors. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2846-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kim, Young S. "Intestinal Mucosal Hydrolysis of Proteins and Peptides." In Ciba Foundation Symposium 50 - Peptide Transport and Hydrolysis. John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470720318.ch9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bolin, D. R., J. M. Cottrell, J. Michalewsky, et al. "Ro 25-1553: a potent, metabolically stable vasoactive intestinal peptide agonist." In Peptides. Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-0683-2_282.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Peptide intestinal"

1

Rosselin, Gabriel. "Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides." In International Symposium on Vasoactive Intestinal Peptide Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814534222.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Röckendorf, Niels, Jürgen Helfmann, Naho Fujimoto, Katrin Wehry, Mario Bürger, and Andreas Frey. "Peptide-based optical contrast agents for targeting of intestinal malignancies." In European Conference on Biomedical Optics. OSA, 2007. http://dx.doi.org/10.1364/ecbo.2007.6633_82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Röckendorf, Niels, Jürgen Helfmann, Naho Fujimoto, Katrin Wehry, Mario Bürger, and Andreas Frey. "Peptide-based optical contrast agents for targeting of intestinal malignancies." In European Conference on Biomedical Optics, edited by Jürgen Popp and Gert von Bally. SPIE, 2007. http://dx.doi.org/10.1117/12.728404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mandal, Jyotshna, Michael Roth, Luigi Costa, et al. "Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.oa2918.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Youssef, J. G., J. Javitt, G. Youssef, and M. Javitt. "Treatment of Sepsis-Related Acute Respiratory Distress Syndrome with Vasoactive Intestinal Peptide." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rubinstein, Israel. "Safety Of Nanomicellar Vasoactive Intestinal Peptide In Mice - Implications For Pulmonary Arterial Hypertension." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3412.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Katlinskaya, Yuliya V., Dhwani Haria, Lily McLaughlin, et al. "Abstract 576: A novel intestinal microbiome-derived peptide modulates host T cell activation." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Katlinskaya, Yuliya V., Dhwani Haria, Lily McLaughlin, et al. "Abstract 576: A novel intestinal microbiome-derived peptide modulates host T cell activation." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sastry, Konduru Seetharama, Aouatef Ismail Chouchane, Ena Wang, Francesco M. Marincola, and Lotfi Chouchane. "Vasoactive Intestinal Peptide Protects Cancer Stem Cells from Apoptosis by Activating Multiple Signaling Pathways." In Qatar Foundation Annual Research Conference Proceedings. Hamad bin Khalifa University Press (HBKU Press), 2016. http://dx.doi.org/10.5339/qfarc.2016.hbpp1932.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Galie, Nazzareno, Anco Boonstra, Ralf Ewert, et al. "Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH)." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2516.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Peptide intestinal' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography